Stable alteration of pre-mRNA splicing patterns by modified U7 small nuclear RNAs
Open Access
- 28 April 1998
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 95 (9) , 4929-4934
- https://doi.org/10.1073/pnas.95.9.4929
Abstract
In several forms of β-thalassemia, mutations in the second intron of the β-globin gene create aberrant 5′ splice sites and activate a common cryptic 3′ splice site upstream. As a result, the thalassemic β-globin pre-mRNAs are spliced almost exclusively via the aberrant splice sites leading to a deficiency of correctly spliced β-globin mRNA and, consequently, β-globin. We have designed a series of vectors that express modified U7 snRNAs containing sequences antisense to either the aberrant 5′ or 3′ splice sites in the IVS2–705 thalassemic pre-mRNA. Transient expression of modified U7 snRNAs in a HeLa cell line stably expressing the IVS2–705 β-globin gene restored up to 65% of correct splicing in a sequence-specific and dose-dependent manner. Cell lines that stably coexpressed IVS2–705 pre-mRNA and appropriately modified U7 snRNA exhibited up to 55% of permanent restoration of correct splicing and expression of full-length β-globin protein. This novel approach provides a potential alternative to gene replacement therapies.Keywords
This publication has 51 references indexed in Scilit:
- Restoration of ß-Globin Gene Expression in Mammalian Cells by Antisense Oligonucleotides That Modify the Aberrant Splicing Patierns of Thalassemic Pre-mRNAsNucleosides and Nucleotides, 1997
- Keratinocyte Gene Therapy for Adenosine Deaminase Deficiency: A Model Approach for Inherited Metabolic DisordersHuman Gene Therapy, 1997
- Modulation of the Specificity and Activity of a Cellular Promoter in an Adenoviral VectorHuman Gene Therapy, 1997
- Expression of small, therapeutic RNAs in human cell nucleiGene Therapy, 1997
- Hydroxyurea and Sickle Cell Anemia Clinical Utility of a Myelosuppressive “Switching” AgentMedicine, 1996
- Retroviral Mediated Transfer of the cDNA for Human Glucocerebrosidase into Hematopoietic Stem Cells of Patients with Gaucher Disease. A Phase I Study. National Institutes of Health, Bethesda, MarylandHuman Gene Therapy, 1996
- Gene Therapy, Concepts, Current Trials and Future DirectionsAnnual Review of Pharmacology and Toxicology, 1993
- Multiple processing-defective mutations in a mammalian histone pre-mRNA are suppressed by compensatory changes in U7 RNA both in vivo and in vitro.Genes & Development, 1991
- Biochemical complementation with RNA in the Xenopus oocyte: A small rna is required for the generation of 3′ histone mRNA terminiCell, 1983
- THE POTENTIAL LIFE SPAN AND ULTIMATE SURVIVAL OF FRESH RED BLOOD CELLS IN NORMAL HEALTHY RECIPIENTS AS STUDIED BY SIMULTANEOUS Cr51 TAGGING AND DIFFERENTIAL HEMOLYSIS 1Journal of Clinical Investigation, 1955